| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.97▲ | 0.98▼ | 0.98▼ | 0.92▲ | 0.97▼ |
| MA10 | 1.01▼ | 1.02▼ | 1.00▼ | 0.89▲ | 1.04▼ |
| MA20 | 1.01▼ | 0.97▼ | 0.93▲ | 0.96▲ | 1.17▼ |
| MA50 | 0.92▲ | 0.91▲ | 0.90▲ | 1.05▼ | 1.13▼ |
| MA100 | 0.90▲ | 0.91▲ | 0.95▲ | 1.20▼ | 7.68▼ |
| MA200 | 0.92▲ | 1.04▼ | 1.05▼ | 1.17▼ | 185,231.68▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | -0.008▼ | 0.001▲ | 0.014▲ | 1.853▲ |
| RSI | 48.588▼ | 51.714▲ | 54.529▲ | 48.823▼ | 23.166▼ |
| STOCH | 18.122▼ | 30.446 | 43.381 | 46.559 | 32.003 |
| WILL %R | -79.556▼ | -79.556▼ | -47.733 | -38.095 | -65.784 |
| CCI | -95.411 | -60.174 | -11.084 | 124.883▲ | -105.980▼ |
|
Wednesday, February 18, 2026 06:25 AM
Stenoparib is being evaluated in combination with temozolomide clinical benefit in relapsed Small Cell Lung CancerTrial is fully funded by the U.S. Department of Veterans Affairs and is open for ...
|
|
Saturday, February 14, 2026 05:31 PM
Allstate (NYSE:ALL) highlighted its SAVE program and new insurance offerings following strong Q4 results. The SAVE program reduced premiums for millions of policyholders while supporting policy growth ...
|
|
Friday, February 06, 2026 12:30 AM
Allstate (NYSE:ALL) executives used the company’s fourth-quarter 2025 earnings call to highlight a sharp improvement in profitability, progress on insurance affordability initiatives, and continued ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/02/26 | 1.075 | 1.075 | 0.94 | 0.9676 | 211,115 |
| 19/02/26 | 0.9006 | 1.09 | 0.9006 | 1.05 | 296,165 |
| 18/02/26 | 0.8483 | 0.95 | 0.8483 | 0.902 | 222,074 |
| 17/02/26 | 0.85 | 0.8719 | 0.7902 | 0.83 | 136,415 |
| 13/02/26 | 0.844 | 0.896 | 0.8233 | 0.8451 | 137,880 |
| 12/02/26 | 0.9182 | 0.9749 | 0.8289 | 0.8453 | 151,697 |
| 11/02/26 | 0.96 | 0.9795 | 0.8847 | 0.90 | 169,917 |
| 10/02/26 | 0.8601 | 1.00 | 0.852 | 0.9302 | 167,825 |
| 09/02/26 | 0.82 | 0.863 | 0.82 | 0.844 | 101,250 |
| 06/02/26 | 0.82 | 0.855 | 0.801 | 0.8307 | 171,265 |
|
|
||||
|
|
||||
|
|